Marshall Wace, LLP Inotiv, Inc. Transaction History
Marshall Wace, LLP
- $81.7 Billion
- Q2 2025
A detailed history of Marshall Wace, LLP transactions in Inotiv, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 122,372 shares of NOTV stock, worth $170,097. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,372
Previous 99,794
22.62%
Holding current value
$170,097
Previous $220,000
0.91%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NOTV
# of Institutions
82Shares Held
8.35MCall Options Held
66.9KPut Options Held
119K-
Balyasny Asset Management LLC Chicago, IL1.65MShares$2.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.38MShares$1.92 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny398KShares$553,1560.0% of portfolio
-
Massar Capital Management, LP Stamford, CT350KShares$486,4990.48% of portfolio
-
Vantage Point Financial LLC Lisle, IL337KShares$467,7980.27% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $35.6M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...